Pentetate Zinc Trisodium
NDC Package 70651-002-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pentetate Zinc Trisodium is zn-DTPA is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination. Marketed by Hameln Pharma Gmbh, this product is identified by NDC 70651-002 and is authorized under FDA application NDA021751.

Identification & Billing

NDC Package Code
70651-002-03
Package Description
10 AMPULE in 1 PACKAGE / 5 mL in 1 AMPULE
Product Code
11-Digit Billing Format
70651000203
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Pentetate Zinc Trisodium
Dosage Form
-
Usage Information
Zn-DTPA is indicated for treatment of individuals with known or suspected internal contamination with plutonium, americium, or curium to increase the rates of elimination.

Regulatory & Marketing

Labeler Name
Hameln Pharma Gmbh
FDA Application #
NDA021751
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-11-2004
End Marketing Date
05-31-2026
Listing Expiration
05-31-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70651-002-03 identifies a specific commercial package of 10 ampule in 1 package / 5 ml in 1 ampule of Pentetate Zinc Trisodium, labeled by Hameln Pharma Gmbh. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hameln Pharma Gmbh on August 11, 2004. The current certification is valid through May 31, 2026.

How is this Hameln Pharma Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70651000203. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70651-002-03
11-Digit CMS (5-4-2)
70651-0002-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.